Li YY - Search Results

1

Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

Liu B, Wang Z, Li HY, Zhang B, Ping B, Li YY. Liu B, et al. Among authors: li yy, li hy. Oncol Rep. 2014 Jun;31(6):2625-34. doi: 10.3892/or.2014.3158. Epub 2014 Apr 25. Oncol Rep. 2014. PMID: 24789328

2

T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.

Wang Z, Li XM, Shang K, Zhang P, Wang CF, Xin YH, Zhou L, Li YY. Wang Z, et al. Among authors: li yy, li xm. Oncol Rep. 2013 Mar;29(3):1245-51. doi: 10.3892/or.2013.2233. Epub 2013 Jan 11. Oncol Rep. 2013. PMID: 23314349

3

Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.

Wang C, Li HY, Liu B, Huang S, Wu L, Li YY. Wang C, et al. Among authors: li yy, li hy. J Surg Res. 2013 Dec;185(2):595-604. doi: 10.1016/j.jss.2013.06.004. Epub 2013 Jun 28. J Surg Res. 2013. PMID: 23845873

4

A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.

Zhang F, Liu B, Wang Z, Yu XJ, Ni QX, Yang WT, Mukaida N, Li YY. Zhang F, et al. Among authors: li yy. Mol Cancer Res. 2013 Dec;11(12):1508-20. doi: 10.1158/1541-7786.MCR-13-0389. Epub 2013 Oct 28. Mol Cancer Res. 2013. PMID: 24165482

5

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.

Liang C, Yu XJ, Guo XZ, Sun MH, Wang Z, Song Y, Ni QX, Li HY, Mukaida N, Li YY. Liang C, et al. Among authors: li yy, li hy. Oncotarget. 2015 Jun 10;6(16):14440-55. doi: 10.18632/oncotarget.3885. Oncotarget. 2015. PMID: 25971209 Free PMC article.

6

miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.

Liang C, Wang Z, Li YY, Yu BH, Zhang F, Li HY. Liang C, et al. Among authors: li yy, li hy. Tumour Biol. 2015 Dec;36(12):9395-403. doi: 10.1007/s13277-015-3679-5. Epub 2015 Jun 26. Tumour Biol. 2015. PMID: 26113407

7

Pancreatic cancer: diagnosis and treatments.

Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Li HY, et al. Among authors: li yy. Tumour Biol. 2015 Mar;36(3):1375-84. doi: 10.1007/s13277-015-3223-7. Epub 2015 Feb 14. Tumour Biol. 2015. PMID: 25680410 Review.

8

Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.

Chen XY, Wang Z, Li B, Zhang YJ, Li YY. Chen XY, et al. Among authors: li yy, li b. Biochem Biophys Res Commun. 2016 Apr 22;473(1):296-302. doi: 10.1016/j.bbrc.2016.03.099. Epub 2016 Mar 22. Biochem Biophys Res Commun. 2016. PMID: 27016481

9

Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway.

Li T, Wang Z, Hou YF, Li YY. Li T, et al. Among authors: li yy. J Cancer. 2017 Jun 2;8(9):1530-1541. doi: 10.7150/jca.18628. eCollection 2017. J Cancer. 2017. PMID: 28775772 Free PMC article.

10

Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.

Li Y, Xi Z, Chen X, Cai S, Liang C, Wang Z, Li Y, Tan H, Lao Y, Xu H. Li Y, et al. Cell Death Dis. 2018 May 1;9(5):538. doi: 10.1038/s41419-018-0574-1. Cell Death Dis. 2018. PMID: 29749405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,655 results

Search Page

Filters